Highlights from the June BPC meeting
At its June 5-8 meeting, the BPC adopted its opinion on a final question from the European Commission on the comparative evaluation of anticoagulant rodenticides. The question was whether some anticoagulant active ingredients have a lower overall risk to human and animal health and the environment than others.
The BPC concludes that it cannot distinguish between the risk and hazard profiles of these substances, which means that all AVKs can be considered equally hazardous. This conclusion will now be forwarded to the European Commission for a decision. Together with the previous opinion on the comparative assessment of November 2022.
Six opinions adopted
In addition, the BPC adopted six opinions on active substances and combinations of product types, and two opinions on Union authorizations. More details on the opinions can be found in the Appendix.
Decisions on authorizations and approvals
The European Commission, together with the EU Member States, makes the final decisions on the approval of active substances and on the Union authorization of biocidal products.
Guidance available soon
The BPC met from June 5-8, 2023, and adopted opinions will be available on ECHA’s website soon. The next meeting will be held in September 2023.
- Appendix to the BPC News [PDF][EN]
- Agenda of the meeting [PDF][EN]
- Rodent traps may be effective in controlling house mouse infestations, November 29, 2022
- Request to the ECHA for the comparative assessment of anticoagulant rodenticides [PDF][EN]
- Approval of active substances
- Union approval
Also Read: ECHA workshop paves way for regulations on non-animal chemicals
This information has been compiled with the greatest possible care, in some cases from different information sources. (Interpretation) errors are not excluded. No legal obligation can therefore be derived from this text. Everyone dealing with this subject has the responsibility to delve into the matter!